Opus Genetics, Inc. (IRD) income statement
IRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.08+0.16 (+4.08%)
Close on Nov 19, 2026Market cap $339.44MP/E –Yield –
Opus Genetics, Inc. financial ratios
See a number that looks wrong?
Close on Nov 19, 2026Market cap $339.44MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||||||||||||||
| Operating margin | -271.9% | -564.7% | -55.5% | 45.7% | -3,854.8% | – | -139.8% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| EBITDA margin | – | – | – | – | – | – | -138.4% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Pre-tax margin | -349.3% | -523.4% | -52.4% | 45.7% | -9,625.3% | – | -205.6% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Net profit margin | -349.3% | -523.4% | -52.4% | 44.9% | -9,625.3% | – | -205.6% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Free cash flow margin | – | – | – | – | – | – | -120.6% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Effective tax rate | – | – | – | 1.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Returns on capital | ||||||||||||||||||||
| Return on equity | -449.4% | -203.2% | -20.8% | 52.3% | -1,295.1% | 234.2% | 133.3% | -190.7% | -149.6% | -51.9% | -63.4% | -94.5% | -85.7% | -61.5% | -107.5% | -183.3% | -252.5% | 447.8% | -213.0% | -201.8% |
| Return on assets | -113.9% | -126.7% | -19.4% | 47.7% | -259.1% | -253.0% | -69.2% | -64.8% | -102.5% | -40.6% | -49.3% | -69.8% | -55.1% | -43.5% | -75.9% | -86.5% | – | – | – | – |
| Return on tangible assets | -113.9% | -126.7% | -19.4% | 47.7% | -259.1% | -253.0% | -69.2% | -64.8% | -102.5% | -40.6% | -49.3% | -69.8% | -55.1% | -43.5% | -75.9% | -86.5% | – | – | – | – |
| Return on invested capital | 116.8% | 207.8% | – | 2,291.8% | 112.6% | 52.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Return on capital employed | -113.5% | -164.5% | -22.0% | 53.2% | -123.7% | -575.7% | -157.3% | -108.0% | – | – | – | – | – | – | – | – | – | – | – | – |
| Return on total capital | -332.7% | -923.2% | – | 52.8% | -488.6% | 148.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| NOPAT | -$30.49M | -$49.04M | -$8.34M | $17.91M | -$17.94M | -$15.77M | -$3.31M | -$16.22M | -$13.71M | -$12.97M | -$14.43M | -$10.48M | -$6.30M | -$5.20M | -$12.74M | -$8.14M | -$5.11M | – | – | – |
| Cash flow quality | ||||||||||||||||||||
| OCF / Sales | -248.3% | -232.7% | -5.8% | 35.9% | -3,288.6% | – | -119.8% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| OCF / Net income | 0.71 | 0.44 | 0.11 | 0.80 | 0.34 | 0.28 | 0.58 | 1.31 | 0.61 | 1.42 | 1.21 | 0.60 | 0.84 | 1.06 | 1.37 | 0.50 | 1.77 | – | – | – |
| FCF / OCF | – | – | – | – | – | 100.0% | 100.7% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| FCF / Net income | – | – | – | – | – | 0.28 | 0.59 | – | – | – | – | – | – | – | – | – | – | – | – | – |
| FCF / EBITDA | – | – | – | – | – | – | 87.1% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Unlevered free cash flow | – | – | – | – | – | -$1.39M | -$2.50M | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Levered free cash flow | – | – | – | – | – | -$6.80M | -$3.62M | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Efficiency | ||||||||||||||||||||
| Asset turnover | 0.33 | 0.24 | 0.37 | 1.06 | 0.03 | 0.00 | 0.34 | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | – | – | – | – |
| Fixed asset turnover | 62.95 | 87.24 | 6,349.67 | 4,981.25 | 49.08 | 0.00 | 44.62 | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | – | – | – | – |
| Receivables turnover | 5.11 | 4.90 | 17.13 | 61.40 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Days sales outstanding | 71.5 | 74.5 | 21.3 | 5.9 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| CapEx to revenue | – | – | – | – | – | – | 0.83% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| CapEx to OCF | – | – | – | – | – | -0.00% | -0.70% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| CapEx to depreciation | – | – | – | – | – | – | 0.61 | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Liquidity | ||||||||||||||||||||
| Current ratio | 6.43 | 3.24 | 13.35 | 17.79 | 6.76 | 5.55 | 0.19 | 5.04 | – | – | – | – | – | – | – | – | – | – | – | – |
| Quick ratio | 6.43 | 3.24 | 13.35 | 17.79 | 6.76 | 5.55 | 0.19 | 5.04 | – | – | – | – | – | – | – | – | – | – | – | – |
| Cash ratio | 5.80 | 2.68 | 12.50 | 15.50 | 6.42 | 5.15 | 1.31 | 0.14 | – | – | – | – | – | – | – | – | – | – | – | – |
| Working capital | $42.26M | $25.32M | $49.91M | $46.23M | $22.21M | $14.48M | -$7.58M | $12.75M | – | – | – | – | – | – | – | – | – | – | – | – |
| Net current asset value | $15.15M | $25.32M | $49.91M | $46.23M | $22.21M | -$13.48M | -$7.58M | $10.42M | $16.62M | $16.94M | $18.63M | $26.48M | $12.36M | $8.39M | $9.18M | $9.85M | – | – | – | – |
| Leverage | ||||||||||||||||||||
| Total debt | $1.13M | $0 | – | $0 | $538.00K | $0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Net debt | -$43.96M | -$30.32M | – | -$42.68M | -$24.22M | -$16.40M | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Debt / Equity | 0.07 | 0.00 | – | 0.00 | 0.02 | -0.00 | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Debt ratio | 2.2% | 0.00% | – | 0.00% | 2.1% | 0.00% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Assets to equity | 3.27 | 5.48 | 1.08 | 1.06 | 1.17 | -1.31 | -0.24 | -9.44 | 1.69 | 1.23 | 1.32 | 1.26 | 1.55 | 1.56 | 1.28 | 1.56 | – | – | – | – |
| Long-term debt to assets | 2.2% | 0.00% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Long-term debt to equity | 0.07 | 0.00 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Total debt / Capitalization | 6.9% | 0.00% | – | 0.00% | 2.4% | -0.00% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Long-term debt / Capitalization | 6.9% | 0.00% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Cash flow to debt | -3,122.5% | – | – | – | -3,600.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Interest coverage | ||||||||||||||||||||
| EBIT / Interest expense | -299.22 | – | – | 2,025.11 | -11,352.50 | -2.92 | -2.98 | – | – | – | – | – | – | – | – | – | – | – | – | – |
| EBITDA / Interest expense | – | – | – | – | – | – | -2.95 | – | – | – | – | – | – | – | – | – | – | – | – | – |
| (EBITDA − CapEx) / Interest expense | – | – | – | – | – | – | -2.96 | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Per share | ||||||||||||||||||||
| Revenue per share | 0.20 | 0.35 | 0.79 | 1.91 | 0.03 | 0.00 | 1.05 | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | – | – | – | – |
| EPS (basic) | -0.80 | -2.15 | -0.46 | 0.90 | -3.82 | -5.28 | -2.17 | -5.25 | -11.04 | -5.16 | -9.48 | -13.20 | -8.40 | -7.20 | -14.40 | -21.60 | -6.00 | – | – | – |
| EPS (diluted) | -0.80 | -2.15 | -0.46 | 0.87 | -3.82 | -5.28 | -2.17 | -5.25 | -11.04 | -5.16 | -9.48 | -13.20 | -8.40 | -7.20 | -14.40 | -21.60 | -6.00 | – | – | – |
| Book value per share | 0.22 | 0.21 | 2.08 | 2.22 | 1.18 | -1.24 | -2.65 | -0.54 | 6.34 | 8.62 | 11.41 | 17.89 | 10.33 | 9.58 | 13.47 | 14.82 | – | – | – | – |
| Tangible book value per share | 0.22 | 0.21 | 2.08 | 2.22 | 1.18 | -1.24 | -2.65 | -0.54 | 6.34 | 8.62 | 11.41 | 17.89 | 10.33 | 9.58 | 13.47 | 14.82 | – | – | – | – |
| Cash per share | 0.65 | 0.96 | 2.11 | 2.05 | 1.31 | 1.51 | 4.28 | 0.14 | 3.37 | 5.85 | 6.20 | 6.62 | 15.28 | 13.55 | 12.41 | 17.60 | – | – | – | – |
| Operating cash flow per share | -0.50 | -0.81 | -0.05 | 0.69 | -1.03 | -0.62 | -1.26 | -6.03 | -5.83 | -6.69 | -10.55 | -7.43 | -6.53 | -6.65 | -19.55 | -9.96 | – | – | – | – |
| Free cash flow per share | – | – | – | – | – | -0.62 | -1.27 | – | – | – | – | – | – | – | – | – | – | – | – | – |
| CapEx per share | – | – | – | – | – | 0.00 | 0.0088 | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Valuation at period end | ||||||||||||||||||||
| Market cap | $129.73M | $31.18M | $68.06M | $73.43M | $64.51M | $29.10M | $30.71M | $118.12M | $229.96M | $132.93M | $260.28M | $499.11M | $274.26M | $118.23M | $144.80M | – | – | – | – | – |
| Enterprise value | $99.99M | -$5.46M | $25.70M | $59.47M | $41.88M | $21.00M | $16.81M | $105.52M | $221.73M | $124.53M | $247.83M | $484.14M | $259.39M | $110.85M | $131.59M | – | – | – | – | – |
| P/E | – | – | – | 4.1x | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| P/S | 9.1x | 2.8x | 3.6x | 1.8x | 110x | – | 10.2x | – | – | – | – | – | – | – | – | – | – | – | – | – |
| P/B | 8.5x | 4.6x | 1.4x | 1.6x | 2.9x | -2.2x | -4.1x | -69.5x | 13.7x | 7.8x | 13.9x | 18.8x | 21.7x | 12.4x | 13.5x | – | – | – | – | – |
| P/TBV | 8.5x | 4.6x | 1.4x | 1.6x | 2.9x | -2.2x | -4.1x | -69.5x | 13.7x | 7.8x | 13.9x | 18.8x | 21.7x | 12.4x | 13.5x | – | – | – | – | – |
| P/OCF | -3.7x | -1.2x | -61.2x | 5.1x | -3.3x | -4.3x | -8.5x | -6.3x | -14.9x | -10.0x | -15.0x | -45.2x | -34.3x | -17.9x | -9.3x | – | – | – | – | – |
| EV/Sales | 7.0x | -0.5x | 1.3x | 1.5x | 71.1x | – | 5.6x | – | – | – | – | – | – | – | – | – | – | – | – | – |
| EV/EBIT | – | 0.1x | – | 3.3x | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| EV/OCF | -2.8x | 0.2x | -23.1x | 4.2x | -2.2x | -3.1x | -4.7x | -5.6x | -14.4x | -9.4x | -14.3x | -43.8x | -32.5x | -16.7x | -8.5x | – | – | – | – | – |
| Earnings yield | -38.2% | -184.5% | -14.7% | 24.4% | -87.9% | -84.6% | -20.1% | -12.2% | -11.0% | -7.0% | -5.5% | -3.7% | -3.5% | -5.3% | -7.8% | – | – | – | – | – |
| FCF yield | – | – | – | – | – | -23.4% | -11.8% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Shareholder yield | ||||||||||||||||||||
| Buyback yield | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00% | – | – | – | – | – |
| Shareholder yield | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00% | – | – | – | – | – |
| Cost structure | ||||||||||||||||||||
| R&D to revenue | 217.0% | 244.3% | 92.7% | 36.0% | 2,576.1% | – | 79.1% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Stock-based comp to revenue | 23.9% | 30.6% | 18.4% | 4.5% | 325.0% | – | 10.3% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Per employee | ||||||||||||||||||||
| Total employees | 27 | 18 | 14 | 9 | 8 | 5 | 5 | 10 | 17 | 20 | 20 | 22 | 16 | 14 | 15 | 14 | 14 | 14 | 14 | 14 |
| Revenue per employee | $525.78K | $610.67K | $1.36M | $4.43M | $73.63K | $0 | $600.00K | – | – | – | – | – | $0 | $0 | $0 | $0 | $0 | – | – | – |
| Gross profit per employee | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -$7.14K | – | – | – |
| Operating profit per employee | -$1.43M | -$3.45M | -$754.50K | $2.03M | -$2.84M | -$3.99M | -$838.60K | -$2.05M | -$1.02M | -$820.67K | -$913.17K | -$603.15K | -$498.68K | -$469.97K | -$1.08M | -$736.14K | -$461.85K | – | – | – |
| Net income per employee | -$1.84M | -$3.20M | -$713.29K | $1.99M | -$7.09M | -$4.92M | -$1.23M | -$1.44M | -$1.49M | -$465.37K | -$719.23K | -$841.89K | -$593.71K | -$444.76K | -$756.33K | -$1.00M | -$207.36K | -$262.99K | -$317.31K | -$463.29K |
| Free cash flow per employee | – | – | – | – | – | -$1.36M | -$723.60K | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Growth | ||||||||||||||||||||
| Revenue 1Y growth | 29.1% | -42.3% | -52.2% | 6,665.7% | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Revenue 3Y CAGR | -29.1% | 165.2% | – | 136.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Revenue 5Y CAGR | – | 29.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| EBIT 1Y growth | 37.8% | -487.7% | -158.0% | 180.3% | -13.7% | -376.2% | 79.6% | -18.3% | -5.7% | 10.1% | -37.6% | -66.3% | -21.3% | 59.2% | -56.5% | -59.4% | – | – | – | – |
| EBITDA 1Y growth | – | – | – | – | – | – | 79.7% | -18.4% | -5.7% | 10.2% | -37.7% | -66.7% | -21.5% | 59.4% | -56.9% | -59.6% | – | – | – | – |
| Net income 1Y growth | 13.8% | -476.1% | -155.8% | 131.6% | -130.3% | -299.1% | 57.1% | 43.2% | -171.8% | 35.3% | 22.3% | -95.0% | -52.6% | 45.1% | 19.1% | -383.0% | 21.2% | 17.1% | 31.5% | – |
| Diluted EPS 1Y growth | 62.8% | -367.4% | -152.9% | 122.8% | 27.7% | -143.3% | 58.7% | 52.4% | -114.0% | 45.6% | 28.2% | -57.1% | -16.7% | 50.0% | 33.3% | -260.0% | – | – | – | – |
| Operating cash flow 1Y growth | -37.8% | -2,200.0% | -107.8% | 173.9% | -185.0% | -89.2% | 80.9% | -22.2% | -16.6% | 23.8% | -57.2% | -38.3% | -20.6% | 57.4% | -122.3% | -35.7% | – | – | – | – |
| Free cash flow 1Y growth | – | – | – | – | – | -87.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| CapEx 1Y growth | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Total assets 1Y growth | 36.3% | -31.7% | 10.1% | 87.9% | 47.5% | 891.1% | -88.9% | -43.3% | 34.4% | -15.2% | -26.0% | 71.5% | 31.1% | 9.0% | -15.6% | – | – | – | – | – |
| Total assets 3Y CAGR | 0.84% | 12.2% | 45.0% | 201.7% | 17.6% | -14.5% | -56.1% | -13.5% | -5.5% | 2.5% | 18.5% | 34.8% | 6.4% | – | – | – | – | – | – | – |
| Total assets 5Y CAGR | 23.2% | 83.2% | 27.4% | 11.6% | 4.4% | -6.5% | -44.4% | -3.9% | 13.7% | 9.0% | 8.9% | – | – | – | – | – | – | – | – | – |
| Total assets 10Y CAGR | 7.3% | 0.95% | 10.7% | 12.6% | 6.7% | 0.87% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Total equity 1Y growth | 128.3% | -86.5% | 7.9% | 108.1% | 265.0% | -78.1% | -345.0% | -110.1% | -1.7% | -9.1% | -29.4% | 110.5% | 32.4% | -10.9% | 3.0% | 112.0% | 288.4% | -371.6% | -70.2% | – |
| Total equity 3Y CAGR | -30.8% | -32.9% | – | – | – | – | – | – | -14.2% | 10.6% | 25.3% | 35.4% | 6.7% | 24.8% | – | 121.4% | 15.1% | – | – | – |
| Total equity 5Y CAGR | – | – | – | 22.5% | 5.4% | – | – | – | 12.0% | 9.8% | 12.6% | 40.2% | – | 58.3% | 27.2% | – | – | – | – | – |
| Total equity 10Y CAGR | -2.0% | -12.8% | 14.7% | 17.1% | 7.6% | – | – | – | 33.1% | 18.2% | – | – | – | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.